Sarilumab
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Sarilumab is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $172 million on Sarilumab across 37,000 claims for 6,254 beneficiaries.
Sarilumab is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $2066.48 to $2074.99 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$2066.48 – $2074.99
per ML
7d Activity
avg +0.2% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing SARILUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
KEVZARA 200 MG/1.14 ML PEN INJ | $2074.9884 per ML | +0.18% |
KEVZARA 200 MG/1.14 ML SYRINGE | $2066.4821 per ML | — |
Frequently Asked Questions
What is Sarilumab used to treat?
Sarilumab is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Sarilumab?
In 2024, Medicare Part D spent $172 million on Sarilumab across 37,000 claims for 6,254 beneficiaries.
How many Sarilumab products are on the market?
The Sarilumab drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Sarilumab?
NADAC reference prices for Sarilumab range from $2066.4821 to $2074.9884 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Sarilumab?
1 manufacturer lists Sarilumab in NADAC. Ranked by number of NDCs, the largest are Sanofi-Aventis U.S. LLC (2).
How has the price of Sarilumab changed recently?
Over the past 7 days, 1 Sarilumab NDC rose and 0 fell, with a market-wide average change of +0.2%.